Differential Diagnosis for Oligomenorrhea in a 25-Year-Old Woman

Primary Differential Diagnoses

The American College of Obstetricians and Gynecologists recommends that polycystic ovary syndrome (PCOS) is the leading cause of oligomenorrhea in reproductive-age women, accounting for approximately 51% of anovulatory oligomenorrhea cases, characterized by hyperandrogenic chronic anovulation with LH/FSH ratio >2, elevated testosterone, and low mid-luteal progesterone indicating anovulation 1, 3
The Endocrine Society suggests that clinical features of PCOS include hirsutism, acne, obesity, truncal obesity, and infertility, with pelvic ultrasound revealing >10 peripheral cysts with thickened ovarian stroma 1, 2
The American Society for Reproductive Medicine indicates that hypothalamic amenorrhea is associated with low LH levels, low estradiol, thin endometrium, and LH/FSH ratio <1, triggered by weight loss, excessive exercise, eating disorders, or psychological stress 3, 5
The European Society of Human Reproduction and Embryology recommends that thyroid dysfunction, both hypothyroidism and hyperthyroidism, can cause menstrual irregularities, with TSH measurement mandatory in the initial workup to identify this reversible cause 2, 3

The American College of Obstetricians and Gynecologists recommends that initial laboratory tests should include pregnancy test, FSH and LH, prolactin, TSH and T4, and testosterone if signs of hyperandrogenism are present, to exclude pregnancy and identify underlying hormonal imbalances 1, 2, 3
The Endocrine Society suggests that additional tests based on clinical presentation may include fasting glucose and insulin, androstenedione, DHEAS, and estradiol, to evaluate for metabolic syndrome, adrenal/ovarian tumors, and non-classical congenital adrenal hyperplasia 1, 2, 4

The American Society for Reproductive Medicine advises against relying on single hormone measurements, as FSH levels fluctuate significantly, and timing during the menstrual cycle is crucial, and against measuring hormones while the patient is on hormonal contraception, as this can affect accuracy 2
The European Society of Human Reproduction and Embryology recommends evaluating for disordered eating, excessive exercise, and low bone density in thin or athletic patients with hypothalamic amenorrhea, and assessing metabolic risk in women with cycles >60 days 3, 5

The American College of Obstetricians and Gynecologists recommends referring patients to a specialist for persistent oligomenorrhea >6 months despite initial evaluation, abnormal hormone levels suggesting specific pathology, signs of hyperandrogenism with menstrual irregularity, infertility concerns, or suspected structural abnormalities on imaging 4, 5